These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 36643758)
21. Map-based cloning of the APRR2 gene controlling green stigma in bitter gourd ( Zhan J; Zhong J; Cheng J; Wang Y; Hu K Front Plant Sci; 2023; 14():1128926. PubMed ID: 37235005 [TBL] [Abstract][Full Text] [Related]
22. Combined genomic, transcriptomic, and metabolomic analyses provide insights into chayote (Sechium edule) evolution and fruit development. Fu A; Wang Q; Mu J; Ma L; Wen C; Zhao X; Gao L; Li J; Shi K; Wang Y; Zhang X; Zhang X; Wang F; Grierson D; Zuo J Hortic Res; 2021 Jan; 8(1):35. PubMed ID: 33517348 [TBL] [Abstract][Full Text] [Related]
23. Genome-Wide Analysis of Simple Sequence Repeats in Bitter Gourd ( Cui J; Cheng J; Nong D; Peng J; Hu Y; He W; Zhou Q; Dhillon NPS; Hu K Front Plant Sci; 2017; 8():1103. PubMed ID: 28690629 [TBL] [Abstract][Full Text] [Related]
25. Emerging Antitumor Activities of the Bitter Melon (Momordica charantia). Fang EF; Froetscher L; Scheibye-Knudsen M; Bohr VA; Wong JH; Ng TB Curr Protein Pept Sci; 2019; 20(3):296-301. PubMed ID: 29932035 [TBL] [Abstract][Full Text] [Related]
26. Accumulation of Charantin and Expression of Triterpenoid Biosynthesis Genes in Bitter Melon (Momordica charantia). Cuong DM; Jeon J; Morgan AMA; Kim C; Kim JK; Lee SY; Park SU J Agric Food Chem; 2017 Aug; 65(33):7240-7249. PubMed ID: 28737900 [TBL] [Abstract][Full Text] [Related]
27. Transcriptome analysis of five different tissues of bitter gourd (Momordica charantia L.) fruit identifies full-length genes involved in seed oil biosynthesis. Ravichandiran K; Parani M Sci Rep; 2022 Sep; 12(1):15374. PubMed ID: 36100691 [TBL] [Abstract][Full Text] [Related]
28. Mining the bitter melon (momordica charantia l.) seed transcriptome by 454 analysis of non-normalized and normalized cDNA populations for conjugated fatty acid metabolism-related genes. Yang P; Li X; Shipp MJ; Shockey JM; Cahoon EB BMC Plant Biol; 2010 Nov; 10():250. PubMed ID: 21080948 [TBL] [Abstract][Full Text] [Related]
29. Çiçek SS Front Pharmacol; 2022; 13():904643. PubMed ID: 35656300 [No Abstract] [Full Text] [Related]
30. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats. Shih CC; Lin CH; Lin WL; Wu JB J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344 [TBL] [Abstract][Full Text] [Related]
31. Antioxidant, cell-protective, and anti-melanogenic activities of leaf extracts from wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) cultivars. Tsai TH; Huang CJ; Wu WH; Huang WC; Chyuan JH; Tsai PJ Bot Stud; 2014 Dec; 55(1):78. PubMed ID: 28510957 [TBL] [Abstract][Full Text] [Related]
32. Bitter Melon ( Sur S; Ray RB Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726914 [TBL] [Abstract][Full Text] [Related]
33. Potential locus W and candidate gene McPRR2 associated with pericarp pigment accumulation in bitter gourd (Momordica charantia L.) revealed via BSA-seq analysis. Guo J; Han X; Wu T; Wang R; Zhao J; Wang R; Tan D; Yan S; Gao J; Huang W; Zhang H; Zhang C Plant Physiol Biochem; 2024 Mar; 208():108515. PubMed ID: 38484681 [TBL] [Abstract][Full Text] [Related]
34. Bortolotti M; Mercatelli D; Polito L Front Pharmacol; 2019; 10():486. PubMed ID: 31139079 [No Abstract] [Full Text] [Related]
35. Evaluation of bitter melon (Momordica charantia) cultivars grown in Texas and levels of various phytonutrients. Perez JL; Jayaprakasha GK; Crosby K; Patil BS J Sci Food Agric; 2019 Jan; 99(1):379-390. PubMed ID: 29888551 [TBL] [Abstract][Full Text] [Related]
36. Fine-mapping and candidate gene analysis of the Mcgy1 locus responsible for gynoecy in bitter gourd (Momordica spp.). Zhong J; Cui J; Liu J; Zhong C; Hu F; Dong J; Cheng J; Hu K Theor Appl Genet; 2023 Mar; 136(4):81. PubMed ID: 36952023 [TBL] [Abstract][Full Text] [Related]
37. Characterization of a soluble phosphatidic acid phosphatase in bitter melon (Momordica charantia). Cao H; Sethumadhavan K; Grimm CC; Ullah AH PLoS One; 2014; 9(9):e106403. PubMed ID: 25203006 [TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity and maternal toxicity attributed to exposure to Trautenmuller AL; de Almeida Soares J; Behm KC; Guimarães LMM; Xavier-Silva KR; Monteiro de Melo A; Caixeta GAB; Abadia Marciano de Paula J; Luiz Cardoso Bailão EF; Amaral VCS J Toxicol Environ Health A; 2023 Jan; 86(1):36-50. PubMed ID: 36529899 [No Abstract] [Full Text] [Related]
39. Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies. Elekofehinti OO; Ariyo EO; Akinjiyan MO; Olayeriju OS; Lawal AO; Adanlawo IG; Rocha JBT Pathophysiology; 2018 Dec; 25(4):327-333. PubMed ID: 29764719 [TBL] [Abstract][Full Text] [Related]
40. Effect of different drying methods on the product quality and bioactive polysaccharides of bitter gourd (Momordica charantia L.) slices. Yan JK; Wu LX; Qiao ZR; Cai WD; Ma H Food Chem; 2019 Jan; 271():588-596. PubMed ID: 30236720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]